2005
DOI: 10.1016/j.jnutbio.2004.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Biotin deficiency stimulates survival pathways in human lymphoma cells exposed to antineoplastic drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 38 publications
0
4
0
Order By: Relevance
“…Fisher's Protected Least Significant Difference procedure was used for posthoc testing (31). For pairwise comparisons the paired t test was used to determine significance of differences (32). Gender effects were not tested.…”
Section: Statisticsmentioning
confidence: 99%
“…Fisher's Protected Least Significant Difference procedure was used for posthoc testing (31). For pairwise comparisons the paired t test was used to determine significance of differences (32). Gender effects were not tested.…”
Section: Statisticsmentioning
confidence: 99%
“…The products of these genes enhance survival of cancer cells (70,137,138), causing resistance to chemotherapy. Research has shown that biotin deficiency enhances the nuclear translocation of NF-κB in Jurkat cells treated with antineoplastic agents such as taxol, doxorubicin, and vinblastine (60). This is associated with increased expression of Bfl-1/A1 and a decreased rate of death in cells treated with doxorubicin and vinblastine.…”
Section: Nuclear Factor-κbmentioning
confidence: 99%
“…, 2005). Moreover, biotin deficiency stimulates nuclear factor κB (NF‐κB) survival pathways (Griffin and Zempleni, 2005; Rodriguez‐Melendez and Zempleni, 2003).…”
Section: Introductionmentioning
confidence: 99%